I heard about Dr. Martha Sedegah for the first time when I was a postdoc in a malaria research lab at the National Institutes of Health, Rockville, MD. I was inspired by her success in such a competitive area as malaria research.
Dr. Sedegah is a Principal Investigator, Director of Clinical Immunology, and Director of Parasitology at the U.S. Naval Medical Research Center (NMRC) in Silver Spring, MD. Dr. Sedegah is also faculty as a mentor for the Postdoctoral Program at the Noguchi Memorial Institute for Medical Research (NMIMR), and an Adjunct Professor at the Department of Microbiology and Immunology, University of Maryland at Baltimore, School of Medicine, Baltimore MD, where she was a Research Assistant Professor. She also collaborates with Sanaria Inc., a biotech company whose only mission is to develop an effective malaria vaccine that will prevent death from this terrible disease. Dr. Sedegah’s research interest at the NMRC is focused on detecting advanced epitope-based malaria vaccines. Her work gives hope to millions of people infected with malaria every year; however, a vaccine is still not available because of the complicated parasite life cycle and its ability to gain resistance to new drugs very quickly.